Search Results - "Lane, Denis"

Refine Results
  1. 1

    Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients by Lane, Denis, Matte, Isabelle, Rancourt, Claudine, Piché, Alain

    Published in BMC cancer (30-05-2011)
    “…The acellular fraction of epithelial ovarian cancer (EOC) ascites promotes de novo resistance of tumor cells and thus supports the idea that tumor cells may…”
    Get full text
    Journal Article
  2. 2

    Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis by Goncharenko-Khaider, Nadzeya, Matte, Isabelle, Lane, Denis, Rancourt, Claudine, Piché, Alain

    Published in Molecular cancer (17-11-2012)
    “…Ascites may affect the progression of ovarian cancer (OC). In particular, soluble factors present in OC ascites can create a protective environment for tumor…”
    Get full text
    Journal Article
  3. 3

    Malignant ascites protect against TRAIL‐induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells by Lane, Denis, Robert, Véronique, Grondin, Roxanne, Rancourt, Claudine, Piché, Alain

    Published in International journal of cancer (15-09-2007)
    “…Ascites are commonly found in ovarian cancer patients with advanced disease and are rich in cellular components and growth‐promoting factors. The purpose of…”
    Get full text
    Journal Article
  4. 4

    Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis by Lane, Denis, Matte, Isabelle, Rancourt, Claudine, Piché, Alain

    Published in Journal of ovarian research (15-11-2012)
    “…Resistance to apoptosis is a major problem in ovarian cancer and correlates with poor prognosis. Osteoprotegerin (OPG) is a secreted factor in malignant…”
    Get full text
    Journal Article
  5. 5

    Antiapoptotic Proteins Bcl-2 and Bcl-XL Inhibit Clostridium difficile Toxin A-Induced Cell Death in Human Epithelial Cells by Matte, Isabelle, Lane, Denis, Côté, Élodie, Asselin, Ann-Élise, Fortier, Louis-Charles, Asselin, Claude, Piché, Alain

    Published in Infection and Immunity (01-12-2009)
    “…It has been well established that Clostridium difficile toxin A (TcdA) induces cell death in human epithelial cells. However, the mechanism of TcdA-induced…”
    Get full text
    Journal Article
  6. 6

    The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer by Lane, Denis, Matte, Isabelle, Rancourt, Claudine, Piché, Alain

    Published in Journal of ovarian research (18-01-2010)
    “…The production of ascites is a common complication of ovarian cancer. Ascites constitute a unique tumor microenvironment that may affect disease progression…”
    Get full text
    Journal Article
  7. 7

    Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3 by Denis Lane, Marceline Côté, Roxanne Grondin, Marie-Christine Couture, Alain Piché

    Published in Molecular cancer therapeutics (01-03-2006)
    “…Little is known on how cancer cells can acquire resistance to tumor necrosis factor–related apoptosis-inducing ligand (TRAIL). In this study, we established…”
    Get full text
    Journal Article
  8. 8

    CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis by Boivin, Marianne, Lane, Denis, Piché, Alain, Rancourt, Claudine

    Published in Gynecologic oncology (01-12-2009)
    “…Abstract Objective Little is known about the biological functions of CA125/MUC16 tumor antigen. Here, we examined the role of CA125/MUC16 in regulating the…”
    Get full text
    Journal Article
  9. 9

    Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers by Lane, Denis, Matte, Isabelle, Garde-Granger, Perrine, Laplante, Claude, Carignan, Alex, Rancourt, Claudine, Piché, Alain

    Published in BMC cancer (01-07-2015)
    “…Platinum-based combination therapy is the standard first-line treatment for women with advanced serous epithelial ovarian carcinoma (EOC). However, about 20 %…”
    Get full text
    Journal Article
  10. 10

    CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling by Lane, Denis, Matte, Isabelle, Laplante, Claude, Garde-Granger, Perrine, Carignan, Alex, Bessette, Paul, Rancourt, Claudine, Piché, Alain

    Published in Molecular cancer (09-09-2016)
    “…Ovarian cancer (OC) ascites consist in a proinflammatory tumor environment that is characterized by the presence of various cytokines, chemokines and growth…”
    Get full text
    Journal Article
  11. 11

    Ovarian cancer ascites enhance the migration of patient‐derived peritoneal mesothelial cells via cMet pathway through HGF‐dependent and ‐independent mechanisms by Matte, Isabelle, Lane, Denis, Laplante, Claude, Garde‐Granger, Perrine, Rancourt, Claudine, Piché, Alain

    Published in International journal of cancer (15-07-2015)
    “…Ovarian cancer ascites consist of a proinflammatory environment that is characterized by the presence of abundant human peritoneal mesothelial cells (HPMCs)…”
    Get full text
    Journal Article
  12. 12

    Profiling of cytokines in human epithelial ovarian cancer ascites by Matte, Isabelle, Lane, Denis, Laplante, Claude, Rancourt, Claudine, Piché, Alain

    Published in American journal of cancer research (01-01-2012)
    “…The behavior of tumor cells is influenced by the composition of the surrounding tumor environment. The importance of ascites in ovarian cancer (OC) progression…”
    Get full text
    Journal Article
  13. 13

    Ascites IL-10 Promotes Ovarian Cancer Cell Migration by Lane, Denis, Matte, Isabelle, Garde-Granger, Perrine, Bessette, Paul, Piché, Alain

    Published in Cancer microenvironment (01-12-2018)
    “…Ovarian cancer (OC) ascites is an inflammatory and immunosuppressive tumor environment characterized by the presence of various cytokines, chemokines and…”
    Get full text
    Journal Article
  14. 14

    Role of malignant ascites on human mesothelial cells and their gene expression profiles by Matte, Isabelle, Lane, Denis, Bachvarov, Dimcho, Rancourt, Claudine, Piché, Alain

    Published in BMC cancer (24-04-2014)
    “…Malignant ascites is often present at diagnostic in women with advanced ovarian cancer (OC) and its presence is associated with a worse outcome. Human…”
    Get full text
    Journal Article
  15. 15

    MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression by Matte, Isabelle, Lane, Denis, Boivin, Marianne, Rancourt, Claudine, Piché, Alain

    Published in BMC cancer (01-04-2014)
    “…MUC16 (CA125) is a large transmembrane mucin protein (> 200 kDa) aberrantly expressed in approximately 80% of human epithelial ovarian cancers (EOC). MUC16…”
    Get full text
    Journal Article
  16. 16

    Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis by Lane, Denis, Matte, Isabelle, Laplante, Claude, Garde-Granger, Perrine, Rancourt, Claudine, Piché, Alain

    Published in Journal of ovarian research (23-11-2013)
    “…Resistance to apoptosis is a major problem in ovarian cancer (OC) and correlates with poor prognosis. Osteoprotegerin (OPG) is a soluble secreted factor that…”
    Get full text
    Journal Article
  17. 17

    Targeted ovarian cancer treatment: the TRAILs of resistance by Khaider, Nadzeya Goncharenko, Lane, Denis, Matte, Isabelle, Rancourt, Claudine, Piché, Alain

    Published in American journal of cancer research (01-01-2012)
    “…Ovarian cancer (OC) is the leading cause of death from gynecological malignancies. Although most patients respond to the initial therapy when presenting with…”
    Get full text
    Journal Article
  18. 18

    Antiapoptotic Proteins Bcl-2 and Bcl-X L Inhibit Clostridium difficile Toxin A-Induced Cell Death in Human Epithelial Cells by Matte, Isabelle, Lane, Denis, Côté, Élodie, Asselin, Ann-Élise, Fortier, Louis-Charles, Asselin, Claude, Piché, Alain

    Published in Infection and immunity (01-12-2009)
    “…It has been well established that Clostridium difficile toxin A (TcdA) induces cell death in human epithelial cells. However, the mechanism of TcdA-induced…”
    Get full text
    Journal Article
  19. 19

    Osteoprotegerin , and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis by Lane, Denis, Matte, Isabelle, Laplante, Claude, Garde-Granger, Perrine, Rancourt, Claudine, Pichñ, Alain

    Published in Journal of ovarian research (23-11-2013)
    “…Background Resistance to apoptosis is a major problem in ovarian cancer (OC) and correlates with poor prognosis. Osteoprotegerin (OPG) is a soluble secreted…”
    Get full text
    Journal Article
  20. 20

    Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells by Lane, Denis, Cartier, Andréanne, L'Espérance, Sylvain, Côté, Marceline, Rancourt, Claudine, Piché, Alain

    Published in Gynecologic oncology (01-06-2004)
    “…Objectives. In this study, we examine the sensitivity of a panel of ovarian carcinoma cells, which includes four primary ovarian cancer cell samples, and four…”
    Get full text
    Journal Article